Business Leaders

Latest NewsCompaniesMarketsEconomy & ForexCommoditiesInterest RatesBusiness LeadersFinance Pro.CalendarSectors 
HomeAll NewsMost read newsBusiness Leaders Biography
Portrait de Owen O'Connor
Country of residence : Unknown
Linked companies : TG Therapeutics, Inc.

Biography of Owen O'Connor 
Owen A. O'Connor founded Therasis, Inc. Currently, he is Chief Scientific Officer for TG Therapeutics, Inc. He is also Director-Center for Lymphoid Malignancies at Columbia Presbyterian Medical Center and Principal at NYU Elaine A. & Kenneth G. Langone Medical Center.


Current positions of Owen O'Connor 
Owen O'Connor : Personal Network 
Most Read News 
05/11CATHIE WOOD : Tumble in Coinbase pushes Wood's ARK fund closer to pandemic low
RE
05/20XAVIER NIEL : UWR shares spike as billionaire Xavier Niel discloses 27% stake
RE
05/12MASAYOSHI SON : SoftBank Vision Fund posts $26 billion loss; Son pledges defence
RE
05/14ELON MUSK : Elon Musk says Twitter legal team told him he violated an NDA
RE
05/11ELON MUSK : Musk's delay in disclosing Twitter stake triggers SEC probe - WSJ
RE
11:14aELON MUSK : In a faceoff with Elon Musk, the SEC blinked
RE
05/19ELON MUSK : Musk says 'Tesla is on my mind 24/7' amid concerns about Twitter distraction
RE
05/10ELON MUSK : Elon Musk says Tesla open to buying a mining company
RE
05/17ELON MUSK : Prominent hedge funds invested in Twitter before Musk unveiled plans
RE
05/17JPMorgan shareholders vote disapproval of CEO Dimon's special payout
RE
More news


© 2022 People and Ownership :   
Owen O'Connor : Connections 


Latest news about Owen O'Connor 
2021TRANSCRIPT : TG Therapeutics, Inc. Presents at H.C. Wainwright 23rd Annual Global Investment Conference, Sep-13-2021 07:00 AM
CI
2021TRANSCRIPT : TG Therapeutics, Inc. Presents at Goldman Sachs 42nd Annual Global Healthcare Conference, Jun-08-2021 01:20 PM
CI
2021TRANSCRIPT : TG Therapeutics, Inc. - Special Call
CI
2020TRANSCRIPT : TG Therapeutics, Inc., Q2 2020 Earnings Call, Aug 10, 2020
CI
2018TRANSCRIPT : TG Therapeutics, Inc. - Shareholder/Analyst Call
CI
2017TRANSCRIPT : TG Therapeutics, Inc. - Shareholder/Analyst Call
CI
2016TRANSCRIPT : TG Therapeutics, Inc. - Shareholder/Analyst Call
CI
More news